Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02473484 : Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Main inclusion criteria:

- Patients with grade III or IV glioma newly diagnosed with histological evidence

- Surgical indication

- Tumor tissue available at biobank of Lille

- Men and women aged ? 18 years

- Informed Consent signed by the patient or his legal representative.

Main exclusion criteria:

- Antecedents of other cancers except basal cell skin cancer or carcinoma in situ of the
uterus cervix

- Previous history of brain radiotherapy

- Anti-tumor systemic treatments (chemotherapy or targeted therapy) prior to surgery of
glioma

- Genetic disease that may cause brain tumor, potentially radiation-induced tumor

- History of degenerative neurological disease prior to diagnosis

- contraindication to MRI
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02473484      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740